RFNGX
Price
$86.44
Change
+$0.53 (+0.62%)
Updated
Jun 6 closing price
Net Assets
146.4B
VITSX
Price
$143.69
Change
+$1.51 (+1.06%)
Updated
Jun 6 closing price
Net Assets
1.82T
Interact to see
Advertisement

RFNGX vs VITSX

Header iconRFNGX vs VITSX Comparison
Open Charts RFNGX vs VITSXBanner chart's image
American Funds Fundamental Invs R6
Price$86.44
Change+$0.53 (+0.62%)
VolumeN/A
Net Assets146.4B
Vanguard Total Stock Market Idx I
Price$143.69
Change+$1.51 (+1.06%)
VolumeN/A
Net Assets1.82T
RFNGX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RFNGX vs. VITSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RFNGX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. RFNGX (146B). VITSX (1.29) and RFNGX (1.29) have matching dividends . RFNGX was incepted earlier than VITSX: RFNGX (16 years) vs VITSX (28 years). RFNGX (0.28) is less costly to investors than VITSX (0.03). RFNGX is a more actively managed with annual turnover of: 28.00 vs. VITSX (2.00). RFNGX has a lower initial minimum investment than VITSX: RFNGX (250) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 10.97 vs. RFNGX (8.91). VITSX return over 5 years is better than : 80.96 vs. RFNGX (51.83).
RFNGXVITSXRFNGX / VITSX
Total Expense Ratio0.280.03933%
Annual Report Gross Expense Ratio0.280.03933%
Fund Existence16 years28 years-
Gain YTD7.4060.833889%
Front LoadN/AN/A-
Min. Initial Investment25050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets146B1.82T8%
Annual Yield % from dividends1.291.29100%
Returns for 1 year8.9110.9781%
Returns for 3 years33.3640.3583%
Returns for 5 years51.8380.9664%
Returns for 10 years70.38180.4939%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRMR2.680.22
+8.94%
Larimar Therapeutics
CATX3.320.20
+6.41%
Perspective Therapeutics
J127.672.67
+2.14%
Jacobs Solutions
HL6.27-0.18
-2.79%
Hecla Mining Company
CYCC0.37-0.24
-38.84%
Cyclacel Pharmaceuticals Inc.